» Articles » PMID: 3605835

Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma. This Official Statement of the American Thoracic Society Was Adopted by the ATS Board of Directors, November 1986

Overview
Specialty Pulmonary Medicine
Date 1987 Jul 1
PMID 3605835
Citations 336
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) and asthma are the major causes of pulmonary disability in the United States, with at least 10 million Americans suffering form COPD and up to 5% of the population afflicted with asthma. Over the past 20 years, major strides have been made in our understanding of the pathophysiology of these disorders, although there are still large gaps in our knowledge. While a number of position papers and statements have been promulgated by the American Thoracic Society concerning various aspects of the diagnosis and treatment of COPD and asthma, it was felt that a review of the overall topic was timely. This statement represents the combined efforts of a Task Group appointed by the Scientific Assemble of Clinical Problems of the American Thoracic Society to accomplish this task. Clearly, we could not cover every aspect of this broad topic nor even provide a detailed review of those areas addressed. We elected instead to concentrate on clinically relevant topics and to provide sufficient data to be useful as a guide as well as to include selected, but in no was exhaustive, references. The first two chapters define the entities and set forth recommendations for diagnosis, hospital admission, and discharge. The remaining four chapters critically review the various facets of therapy. We have noted controversial areas and those were conclusive experimental data are not yet available. In these situations, the committee often decided to take a position on one side or the other based upon the best available information.

Citing Articles

Zéro allergie research clinic: a clinical and research initiative in oral immunotherapy for managing IgE-mediated food allergy.

Tremblay B, Begin P, Gagnon-Brassard F, Boucher-Lafleur A, Lavoie M, Madore A Allergy Asthma Clin Immunol. 2024; 20(1):59.

PMID: 39488713 PMC: 11531141. DOI: 10.1186/s13223-024-00921-8.


Relationship of Pulmonary Vascular Structure and Function With Exercise Capacity in Health and COPD.

Collins S, Kirby M, Smith B, Tan W, Bourbeau J, Thompson S Chest. 2024; 167(2):402-413.

PMID: 39368737 PMC: 11867894. DOI: 10.1016/j.chest.2024.09.027.


Beyond the Spirometry: New Diagnostic Modalities in Chronic Obstructive Pulmonary Disease.

Song J, Kim Y Tuberc Respir Dis (Seoul). 2024; 88(1):1-13.

PMID: 39308278 PMC: 11704728. DOI: 10.4046/trd.2024.0040.


A Rising STAR in Chronic Obstructive Pulmonary Disease or More Deckchair Rearrangement?.

Calverley P Am J Respir Crit Care Med. 2024; 210(11):1285-1287.

PMID: 38950167 PMC: 11622432. DOI: 10.1164/rccm.202405-0987ED.


Inhaled systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis.

Papadopoulou E, Bin Safar S, Khalil A, Hansel J, Wang R, Corlateanu A Eur Respir Rev. 2024; 33(171).

PMID: 38508668 PMC: 10951861. DOI: 10.1183/16000617.0151-2023.